Research ArticleIMMUNOTHERAPY

Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo

See allHide authors and affiliations

Science Immunology  24 Feb 2017:
Vol. 2, Issue 8, eaal2568
DOI: 10.1126/sciimmunol.aal2568

Article Information

vol. 2 no. 8

PubMed: 
Published By: 
History: 
  • Received October 25, 2016
  • Accepted January 12, 2017

Author Information

  1. Aude G. Chapuis1,*,
  2. Cindy Desmarais2,
  3. Ryan Emerson2,
  4. Thomas M. Schmitt1,
  5. Kendall C. Shibuya1,,
  6. Ivy P. Lai1,,
  7. Felecia Wagener1,
  8. Jeffrey Chou1,§,
  9. Ilana M. Roberts1,ǁ,
  10. David G. Coffey1,
  11. Edus H. Warren1,
  12. Harlan Robins1,2,
  13. Philip D. Greenberg1,3 and
  14. Cassian Yee1,*,
  1. 1Program in Immunology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
  2. 2Adaptive Biotechnologies, Suite 200, 1551 Eastlake Avenue North, Seattle, WA 98103, USA.
  3. 3Department of Immunology, University of Washington, South Lake Union, Building E, 750 Republican Street, Seattle, WA 98109, USA.
  1. *Corresponding author. Email: achapuis{at}fredhutch.org (A.G.C.); cyee{at}mdanderson.org (C.Y.)
  1. ǁ Present address: University of Washington, 1410 Northeast Campus Parkway, Seattle, WA 98195, USA.

  • Present address: Western University of Health Sciences, 309 East 2nd Street, Pomona, CA 91766, USA.

  • Present address: MD Anderson Cancer Center, 7455 Fannin Street, Houston, TX 77054, USA.

  • § Present address: Pfizer Inc., 230 East Grand Avenue, South San Francisco, CA 94080, USA.

AltMetrics

Article usage

AbstractFullPDF
Feb 2017343285213
Mar 20173236127288
Apr 20176252488
May 20177343383
Jun 20173791839
Jul 20173091117
Aug 20172811120
Sep 2017236915
Oct 20171881318